Civilians R&D in Process: Deborah Yarchun
Deborah Yarchun discusses "Drive," a new play exploring the lives of truck drivers who must compete with self-driving vehicles. "Drive" is being developed in the 2018-19 R&D Group.
Sign up to get spam-free email updates on special feature articles, live events and performances from The Civilians.
Deborah Yarchun discusses "Drive," a new play exploring the lives of truck drivers who must compete with self-driving vehicles. "Drive" is being developed in the 2018-19 R&D Group.
R&D Program Director Megan McClain interviews Associate Artist Rebecca Hart about her project with composer David Kornfeld being developed in the Civilians R&D Group. Based partly on their own neurodiverse lives, the work asks questions about creativity, sanity, and what we consider "normal."
Stacey Rose discusses her relationship to Trap music and how it inspired "TRAPT," a new play she is developing in the Civilians R&D Group.
R&D Program Director Megan McClain discusses the projects presented as part of the 2018 R&D FINDINGS Series and invites people to apply for the 2018-19 R&D Group.
Molly Beach Murphy, Jeanna Phillips, and Annie Tippe share the inspiration behind "Untitled CREDIT Project," a new music-theater fantasia that examines America's volatile relationship to money and our addictive love affair with live television.
Eva von Schweinitz, the lead artist of "The Space between the Letters," discusses how her deep dive into adult literacy inspired her most recent work. Incorporating interviews and devising techniques, this project is being developed in the Civilians R&D Group.
Writer, composer and lyricist Deepali Gupta discusses some research topics for "I Love You Stranger," a new musical which takes a personal look at bipolar disorder. Navigating a balance of research and memoir, this work is being developed in the Civilians R&D Group.
Writer, composer and lyricist Zack Zadek discusses how growing up on Long Island has inspired his new work, "Store Brand," which he is developing in the Civilians R&D Group.